US-based Inova Labs, developer of products to treat chronic obstructive pulmonary disease, has received the CE Mark for its LifeChoice portable oxygen concentrator system.

LifeChoice delivers oxygen to patients using a proprietary ‘pulse wave’ technology, which ensures that the patient receives maximum benefit.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The system also has am automatic mode that enables the patient to receive the prescribed oxygen dose even while asleep.

The company is planning to begin commercialisation of LifeChoice in the European region in early 2012.

The device has also been approved by the US Food and Drug Administration.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
HemoSonics has won the 2025 Marketing Award for its impactful promotion of theQuantra Hemostasis System and leadership in blood management education. See how targeted campaigns, thought leadership content, and hands on clinician training are accelerating Quantra’s market traction and shaping the future of hemostasis testing.

Discover the Impact